home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Schrodinger, Inc. - Common Stock (NQ:SDGR)

17.98 +0.10 (+0.56%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Schrödinger to Participate in Upcoming Investor Conferences

February 20, 2024

From Schrödinger

Via Business Wire

Double Your Money: 3 Growth Stocks to Grab in 2024 ↗

February 19, 2024

The Russell 2000 has risen recently as interest rates have climbed, showing that the Street is now more likely to embrace growth stocks.

Via InvestorPlace

AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics ↗

February 19, 2024

The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway.

Via Talk Markets

Topics Artificial Intelligence

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

February 16, 2024

From Schrödinger

Via Business Wire

Key Takeaways From Schrodinger Analyst Ratings ↗

January 26, 2024

Via Benzinga

Is Schrödinger Stock a Buy Now? ↗

November 02, 2023

Its groundbreaking work is winning it some powerful fans, but it's still risky.

Via The Motley Fool

Schrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28

February 14, 2024

From Schrödinger

Via Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

January 19, 2024

From Schrödinger

Via Business Wire

Schrödinger Provides Update on Progress Across the Business and Outlines 2024 Development and Operational Goals

January 08, 2024

From Schrödinger

Via Business Wire

AI-Focused Drug Discovery Stocks Index Up 26% In December ↗

December 29, 2023

With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions.

Via Talk Markets

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

December 19, 2023

From Schrödinger

Via Business Wire

These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest? ↗

December 18, 2023

2024 is going to be a sizzler in the biopharma sector.

Via The Motley Fool

AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week ↗

December 17, 2023

A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method.

Via Talk Markets

Topics Artificial Intelligence

Schrödinger Highlights Progress of Clinical Programs and Discloses Three New Programs at First Therapeutics Pipeline Investor Event

December 14, 2023

From Schrödinger

Via Business Wire

Artificial Intelligence in Healthcare: 3 Stocks Transforming the Industry ↗

December 11, 2023

Companies are applying AI in healthcare, leading to better outcomes and stronger performance for their stocks.

Via InvestorPlace

Topics Artificial Intelligence

The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week ↗

December 11, 2023

If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to...

Via Talk Markets

Topics Artificial Intelligence

Schrödinger Presents Data Supporting Advancement of SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting

December 10, 2023

From Schrödinger

Via Business Wire

Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November ↗

December 06, 2023

The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions.

Via Talk Markets

Topics Artificial Intelligence

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

November 17, 2023

From Schrödinger

Via Business Wire

3 Cutting-Edge Biotech Stocks for the Bold Investor ↗

November 14, 2023

With broader market concerns rising, investors may want to consider the relatively insulated allure of biotech stocks to buy.

Via InvestorPlace

AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence ↗

November 09, 2023

We’re still in the initial stages of a massively disruptive artificial intelligence (AI) boom that's greatly impacting healthcare.

Via InvestorPlace

Topics Artificial Intelligence

Schrödinger to Participate in Upcoming Investor Conferences

November 06, 2023

From Schrödinger

Via Business Wire

3 Top Publicly Traded Companies Leading the AI Revolution ↗

November 04, 2023

Recent data indicates that AI is already saving companies a great deal of money. Here are three AI stocks to buy to exploit the trend.

Via InvestorPlace

Topics Artificial Intelligence

Schrödinger to Present New Data for SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting

November 02, 2023

From Schrödinger

Via Business Wire

Schrödinger Reports Third Quarter 2023 Financial Results

November 01, 2023

From Schrödinger

Via Business Wire

Earnings Scheduled For November 1, 2023 ↗

November 01, 2023

Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.

Via Benzinga

Schrödinger to Host Pipeline Day on December 14, 2023

October 30, 2023

From Schrödinger

Via Business Wire

3 Bill Gates Stocks to Buy for Billionaire-Like Returns ↗

October 27, 2023

Microsoft and Berkshire Hathaway are the two most popular Bill Gates stocks. Investors know these three others far less.

Via InvestorPlace

This Artificial Intelligence (AI) Stock Is Powering the Biotech Revolution: Should You Invest? ↗

October 25, 2023

There's more to the AI boom than Microsoft and ChatGPT.

Via The Motley Fool

Topics Artificial Intelligence

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

October 23, 2023

From Schrödinger

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com